Impaired renal allograft, but not patient survival, in patients with antibodies to hepatitis C virus

Abstract

In the Irish renal transplant population, the presence of hepatitis C antibodies, before or after transplantation is associated with worse long-term graft, but not patient survival.

Hepatic dysfunction in kidney transplant recipients: prevalence and impact on graft and patient survival

“…Furthermore, it was reported that graft survival was lower in HCV-positive recipients than in HCV-negative recipients at 1, 5, and 10 years (75%, 40%, and 14% vs 85%, 62%, and 40%, respectively; P = 0.008), while patient survival was similar in the two groups (P = 0.78). 32 The better outcome of the HCVpositive hepatic group patients at our center might be explained by the strict inclusion criteria for the transplant waiting list.…”